Navigating venous thromboembolism risks in lung cancer patients.
作者信息
Chiu Si-Wai Vivian, Hung Chao-Ming, Chen Jiun-Rung, Yeh Li-Ren, Chiu Chong-Chi
机构信息
Center for Computational Molecular Biology, Brown University, Providence, Rhode Island, USA.
Department of Economics, Brown University, Providence, Rhode Island, USA.
出版信息
Thorac Cancer. 2024 May;15(14):1195-1196. doi: 10.1111/1759-7714.15290. Epub 2024 Apr 3.
Abstract
摘要
相似文献
1
Navigating venous thromboembolism risks in lung cancer patients.应对肺癌患者的静脉血栓栓塞风险
Thorac Cancer. 2024 May;15(14):1195-1196. doi: 10.1111/1759-7714.15290. Epub 2024 Apr 3.
2
Venous and Lung Thromboembolism in the Context of Lung Cancer: Clinical Manifestations, Risk Factors and Prognosis.肺癌背景下的静脉和肺血栓栓塞：临床表现、危险因素及预后
Acta Med Port. 2019 Oct 1;32(10):647-653. doi: 10.20344/amp.10260.
3
Predictors of Venous Thromboembolism and Early Mortality in Lung Cancer: Results from a Global Prospective Study (CANTARISK).肺癌静脉血栓栓塞症和早期死亡率的预测因素：一项全球前瞻性研究（CANTARISK）的结果。
Oncologist. 2018 Feb;23(2):247-255. doi: 10.1634/theoncologist.2017-0205. Epub 2017 Sep 26.
4
Are direct oral anticoagulants an economically attractive alternative to low molecular weight heparins in lung cancer associated venous thromboembolism management?直接口服抗凝剂在肺癌相关静脉血栓栓塞症管理中作为低分子肝素的经济吸引力替代物？
J Thromb Thrombolysis. 2020 Oct;50(3):642-651. doi: 10.1007/s11239-020-02047-1.
5
The performance of Khorana risk score for prediction of venous thromboembolism in patients with lung cancer: A retrospective cohort study.可拉纳风险评分预测肺癌患者静脉血栓栓塞的效能：一项回顾性队列研究。
Tuberk Toraks. 2024 Jun;72(2):114-119. doi: 10.5578/tt.202402921.
6
Dynamics of D-dimer in non-small cell lung cancer patients receiving radical surgery and its association with postoperative venous thromboembolism.非小细胞肺癌患者接受根治性手术时 D-二聚体的动态变化及其与术后静脉血栓栓塞的关系。
Thorac Cancer. 2020 Sep;11(9):2483-2492. doi: 10.1111/1759-7714.13559. Epub 2020 Jul 13.
7
Venous and Arterial Thromboembolism in Patients with Metastatic Lung Cancer.转移性肺癌患者的静脉和动脉血栓栓塞症。
Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296231159121. doi: 10.1177/10760296231159121.
8
Venous Thromboembolism in Patents With Lung Cancer.肺癌患者的静脉血栓栓塞症。
Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620977910. doi: 10.1177/1076029620977910.
9
A systematic review of risk prediction model of venous thromboembolism for patients with lung cancer.系统评价肺癌患者静脉血栓栓塞症的风险预测模型。
Thorac Cancer. 2024 Feb;15(4):277-285. doi: 10.1111/1759-7714.15219. Epub 2024 Jan 17.
10
本文引用的文献
1
A systematic review of risk prediction model of venous thromboembolism for patients with lung cancer.系统评价肺癌患者静脉血栓栓塞症的风险预测模型。
Thorac Cancer. 2024 Feb;15(4):277-285. doi: 10.1111/1759-7714.15219. Epub 2024 Jan 17.
2
Management of venous thromboembolism in patients with lung cancer: a state-of-the-art review.肺癌患者静脉血栓栓塞症的管理：最新综述。
BMJ Open Respir Res. 2023 Apr;10(1). doi: 10.1136/bmjresp-2022-001493.
3
A Comprehensive Review of Risk Factors for Venous Thromboembolism: From Epidemiology to Pathophysiology.静脉血栓栓塞症风险因素的全面综述：从流行病学到病理生理学。
Int J Mol Sci. 2023 Feb 5;24(4):3169. doi: 10.3390/ijms24043169.
4
Validation of risk assessment models predicting venous thromboembolism in acutely ill medical inpatients: A cohort study.预测急性病内科住院患者静脉血栓栓塞的风险评估模型的验证：一项队列研究。
J Thromb Haemost. 2020 Jun;18(6):1398-1407. doi: 10.1111/jth.14796. Epub 2020 Apr 16.
Zotero 插件